Iperion Ltd
IPR
Company Profile
Business description
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.
Contact
c/o Duncan Cotterill
50 Customhouse Quay
Level 5 Tower Building
WellingtonNTL6011
NZLT: +64 272428485
Sector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
31 March 2027
Employees
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,024.20 | 27.20 | -0.30% |
| CAC 40 | 8,211.24 | 54.81 | 0.67% |
| DAX 40 | 24,138.16 | 56.74 | -0.23% |
| Dow JONES (US) | 49,289.97 | 200.06 | -0.40% |
| FTSE 100 | 10,433.50 | 42.96 | -0.41% |
| HKSE | 25,915.20 | 248.04 | -0.95% |
| NASDAQ | 24,582.35 | 75.21 | -0.31% |
| Nikkei 225 | 59,140.23 | 445.63 | -0.75% |
| NZX 50 Index | 12,884.93 | 60.67 | -0.47% |
| S&P 500 | 7,124.59 | 13.31 | -0.19% |
| S&P/ASX 200 | 8,793.40 | 26.10 | -0.30% |
| SSE Composite Index | 4,093.25 | 13.01 | -0.32% |